We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,558 results
  1. Kidney Disease and Proteomics: A Recent Overview of a Useful Tool for Improving Early Diagnosis

    Kidney disease is a critical and potentially life-threatening degenerative condition that poses a significant global public health challenge due to...
    Nicolly Emanuelle de Souza Barcelos, Maria Laura Limeres, ... Diogo B. Peruchetti in Mass Spectrometry-Based Approaches for Treating Human Diseases and Diagnostics
    Chapter 2024
  2. Chronic Kidney Disease: Challenges in Translational Medicine

    Chronic kidney disease (CKD) has long been recognized as a state of progressive decline in renal function. Morbidity and mortality are well...
    Bruno Freire Botelho, André Luis Barreira, ... Marcelo Marcos Morales in Gene, Drug, and Tissue Engineering
    Protocol 2023
  3. Evaluation of a proteomic signature coupled with the kidney failure risk equation in predicting end stage kidney disease in a chronic kidney disease cohort

    Background

    The early identification of patients at high-risk for end-stage renal disease (ESRD) is essential for providing optimal care and...

    Carlos Raúl Ramírez Medina, Ibrahim Ali, ... Nophar Geifman in Clinical Proteomics
    Article Open access 18 May 2024
  4. Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants

    Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressively enlarging cysts. Here we elucidate the interplay between...

    Nastaran Daneshgar, Andrew W. Baguley, ... Dao-Fu Dai in Communications Biology
    Article Open access 20 October 2021
  5. The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease

    Autosomal-dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease and is characterized by progressive growth of...

    Abeda Jamadar, Sreenath M. Suma, ... Reena Rao in Cell Death & Disease
    Article Open access 14 October 2021
  6. HIF-1α promotes kidney organoid vascularization and applications in disease modeling

    Background

    Kidney organoids derived from human pluripotent stem cells (HiPSCs) hold huge applications for drug screening, disease modeling, and cell...

    Kexin Peng, Wanqin **e, ... Zhiyuan Li in Stem Cell Research & Therapy
    Article Open access 19 November 2023
  7. Genetic variants affecting mitochondrial function provide further insights for kidney disease

    Background

    Chronic kidney disease (CKD) is a complex disorder that has become a high prevalence global health problem, with diabetes being its...

    Marisa Cañadas-Garre, Blanca Baños-Jaime, ... Amy Jayne McKnight in BMC Genomics
    Article Open access 10 June 2024
  8. Role of ferroptosis in chronic kidney disease

    Chronic kidney disease (CKD) has historically been a significant global health concern, profoundly impacting both life and well-being. In the process...

    Shiyang Li, Qiuxia Han, ... Dongwei Liu in Cell Communication and Signaling
    Article Open access 12 February 2024
  9. The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease

    Background

    Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might...

    Gurparneet Kaur Sohi, Naba Farooqui, ... Sandra M. Herrmann in Stem Cell Research & Therapy
    Article Open access 09 June 2024
  10. Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry

    Background

    Halting progression of chronic kidney disease (CKD) to established end stage kidney disease is a major goal of global health research. The...

    Carlos R. Ramírez Medina, Ibrahim Ali, ... Nophar Geifman in Clinical Proteomics
    Article Open access 20 April 2023
  11. Adenine base editor corrected ADPKD point mutations in hiPSCs and kidney organoids

    Autosomal dominant polycystic kidney disease (ADPKD) is a dominant genetic disorder caused primarily by mutations in the PKD1 gene, resulting in the...

    **gwen Wang, Yanling Qiu, ... Junjiu Huang in Advanced Biotechnology
    Article Open access 11 June 2024
  12. Association of TCF7L2 Gene Variant (rs12255372) with Polycystic Ovary Syndrome and its Effect Modification of the Disease Phenotype

    Polycystic ovary syndrome (PCOS) and type-2 diabetes mellitus (T2DM) share common genetic features. Transcription factor 7-like-2 (TCF7L2 ) is...

    Rabiya Rashid, Idrees A. Shah, ... Mohd Ashraf Ganie in Indian Journal of Clinical Biochemistry
    Article 30 January 2023
  13. Hyaluronan in Kidney Fibrosis

    The kidney is the organ responsible for the regulation of the body’s fluid balance. Hyaluronan (HA), because of its unique hydration capacity, is...
    Irina Grigorieva, Emma L. Woods, ... Soma Meran in Hyaluronan
    Chapter 2023
  14. Tubular TMEM16A promotes tubulointerstitial fibrosis by suppressing PGC-1α-mediated mitochondrial homeostasis in diabetic kidney disease

    Tubulointerstitial fibrosis (TIF) plays a crucial role in the progression of diabetic kidney disease (DKD). However, the underlying molecular...

    Jia-Ling Ji, Jun-Ying Li, ... Zuo-Lin Li in Cellular and Molecular Life Sciences
    Article 06 November 2023
  15. Assessment of the Phytochemical Constituents and Metabolites in Medicinal Plants and Herbal Remedies Used in the Treatment and Management of Reproductive Diseases: Polycystic Ovary Syndrome

    The present study explores the phytochemical constituents and metabolites found in medicinal plants and herbal remedies traditionally used for...
    Prasann Kumar, Subham Saurabh, Khushbu Sharma in Herbal Medicine Phytochemistry
    Reference work entry 2024
  16. Assessment of the Phytochemical Constituents and Metabolites in Medicinal Plants and Herbal Remedies Used in the Treatment and Management of Reproductive Diseases: Polycystic Ovary Syndrome

    The present study explores the phytochemical constituents and metabolites found in medicinal plants and herbal remedies traditionally used for...
    Prasann Kumar, Subham Saurabh, Khushbu Sharma in Herbal Medicine Phytochemistry
    Living reference work entry 2024
  17. Serum Magnesium Levels in Patients with Chronic Kidney Disease: Is There a Relationship with Inflammation Status?

    Background: Magnesium (Mg 2+ ) is a fundamental mineral that maintains cellular function, and low levels may be linked to inflammation in patients with...

    Julie Ann Kemp, Isadora K Britto, ... Denise Mafra in Biological Trace Element Research
    Article 02 September 2023
  18. Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis

    Background

    Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a...

    Daopeng Dai, Zhengbin Zhu, ... **zhou Zhu in BMC Biology
    Article Open access 10 July 2023
  19. Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases

    Kidney diseases remain one of the leading causes of human death and have placed a heavy burden on the medical system. Regulated cell death...

    **ghan Li, Sujuan Zheng, ... Ke Tan in Cell Death & Disease
    Article Open access 22 September 2023
Did you find what you were looking for? Share feedback.